To investigate the clinical relevance of FUT4 and Sp1, PBMCs from 50 AML patients were isolated to directly compare FUT4 and Sp1 levels in paired CD34 + CD38- LSCs and non-LSCs (the rest cells). The gene discussed is SP1; the disease is acute myeloid leukemia.